This NF2 Meetup was titled “NF2 Meetup: Progress Update on the NF2-INTUITT Clinical Trial.” Recorded live in May of 2023, this NF2 Meetup discussed an exciting progress update on the NF2-INTUITT clinical trial, a first-of-its-kind platform trial dedicated to treatment for NF2-related schwannomatosis (NF2).
The first drug entered into the NF2-INTUITT trial was Brigatinib, which showed promise as a result of CTF’s groundbreaking Synodos for NF2 research collaboration. CTF has proudly continued this investment as a co-funder of this trial. This webinar shares the latest on this promising progress, and CTF’s commitment bringing more drugs into the platform trial.
Closed Captions are available by clicking the CC button.
To read or download the transcript of this recording, CLICK HERE.
To learn more about the NF2 Accelerator Initiative, CLICK HERE.
